QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (46) Citing Articles via Google Scholar Google Scholar Articles by Zhang, W. Articles by Wess, J. Search for Related Content PubMed PubMed Citation Articles by Zhang, W. Articles by Wess, J.

 Previous Article  |  Next Article 

The Journal of Neuroscience, August 1, 2002, 22(15):6347-6352

Multiple Muscarinic Acetylcholine Receptor Subtypes Modulate Striatal Dopamine Release, as Studied with M₁-M₅ Muscarinic Receptor Knock-Out Mice

Weilie Zhang, Masahisa Yamada, Jesus Gomeza, Anthony S. Basile, and Jürgen Wess

Laboratory of Bioorganic Chemistry, National Institutes of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland 20892

A proper balance between striatal muscarinic cholinergic and dopaminergic neurotransmission is required for coordinated locomotor control. Activation of striatal muscarinic acetylcholine receptors (mAChRs) is known to modulate striatal dopamine release. To identify the mAChR subtype(s) involved in this activity, we used genetically altered mice that lacked functional M₁-M₅ mAChRs [knock-out (KO) mice]. In superfused striatal slices from wild-type mice, the non-subtype-selective muscarinic agonist oxotremorine led to concentration-dependent increases in potassium-stimulated [³H]dopamine release (by up to 60%). The lack of M₁ or M₂ receptors had no significant effect on the magnitude of these responses. Strikingly, oxotremorine-mediated potentiation of stimulated striatal [³H]dopamine release was abolished in M₄ receptor KO mice, significantly increased in M₃ receptor-deficient mice, and significantly reduced (but not abolished) in M₅ receptor KO mice. Additional release studies performed in the presence of tetrodotoxin suggested that the dopamine release-stimulating M₄ receptors are probably located on neuronal cell bodies, but that the release-facilitating M₅ and the release-inhibiting M₃ receptors are likely to be located on nerve terminals. Studies with the GABA_A receptor blocker bicuculline methochloride suggested that M₃ and M₄ receptors mediate their dopamine release-modulatory effects via facilitation or inhibition, respectively, of striatal GABA release. These results provide unambiguous evidence that multiple mAChR subtypes are involved in the regulation of striatal dopamine release. These findings should contribute to a better understanding of the important functional roles that the muscarinic cholinergic system plays in striatal function.

Key words: acetylcholine; dopamine release; knock-out mice; muscarinic receptors; oxotremorine; striatum

---

Copyright © 2002 Society for Neuroscience  0270-6474/02/22156347-06$05.00/0

This article has been cited by other articles:

				C. K. Jones, A. E. Brady, A. A. Davis, Z. Xiang, M. Bubser, M. N. Tantawy, A. S. Kane, T. M. Bridges, J. P. Kennedy, S. R. Bradley, et al. Novel Selective Allosteric Activator of the M1 Muscarinic Acetylcholine Receptor Regulates Amyloid Processing and Produces Antipsychotic-Like Activity in Rats J. Neurosci., October 8, 2008; 28(41): 10422 - 10433. [Abstract] [Full Text] [PDF]

				B. N. Armbruster, X. Li, M. H. Pausch, S. Herlitze, and B. L. Roth From the Cover: Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligand PNAS, March 20, 2007; 104(12): 5163 - 5168. [Abstract] [Full Text] [PDF]

				M. Thomsen, D. P. D. Woldbye, G. Wortwein, A. Fink-Jensen, J. Wess, and S. B. Caine Reduced Cocaine Self-Administration in Muscarinic M5 Acetylcholine Receptor-Deficient Mice J. Neurosci., September 7, 2005; 25(36): 8141 - 8149. [Abstract] [Full Text] [PDF]

				W. Shen, S. E. Hamilton, N. M. Nathanson, and D. J. Surmeier Cholinergic Suppression of KCNQ Channel Currents Enhances Excitability of Striatal Medium Spiny Neurons J. Neurosci., August 10, 2005; 25(32): 7449 - 7458. [Abstract] [Full Text] [PDF]

				T. Takeuchi, K. Fujinami, H. Goto, A. Fujita, M. M. Taketo, T. Manabe, M. Matsui, and F. Hata Roles of M2 and M4 Muscarinic Receptors in Regulating Acetylcholine Release From Myenteric Neurons of Mouse Ileum J Neurophysiol, May 1, 2005; 93(5): 2841 - 2848. [Abstract] [Full Text] [PDF]

				L. A. Volpicelli-Daley, A. Hrabovska, E. G. Duysen, S. M. Ferguson, R. D. Blakely, O. Lockridge, and A. I. Levey Altered Striatal Function and Muscarinic Cholinergic Receptors in Acetylcholinesterase Knockout Mice Mol. Pharmacol., December 1, 2003; 64(6): 1309 - 1316. [Abstract] [Full Text] [PDF]

				N. Struckmann, S. Schwering, S. Wiegand, A. Gschnell, M. Yamada, W. Kummer, J. Wess, and R. V. Haberberger Role of Muscarinic Receptor Subtypes in the Constriction of Peripheral Airways: Studies on Receptor-Deficient Mice Mol. Pharmacol., December 1, 2003; 64(6): 1444 - 1451. [Abstract] [Full Text] [PDF]

				H. Li, T. Wyman, Z.-X. Yu, S.-H. Li, and X.-J. Li Abnormal association of mutant huntingtin with synaptic vesicles inhibits glutamate release Hum. Mol. Genet., August 15, 2003; 12(16): 2021 - 2030. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help